StreetAlpha.app
Home › Stocks › HTFL

Heartflow, Inc. (HTFL)

Healthcare
$46.69
▲ +4.62%
LAST CLOSE · NOV 20

Heartflow sells AI software that analyzes heart CT scans to help doctors diagnose coronary artery disease. It last closed at $46.69 on Nov 20, up 4.62% on the day. The next earnings report for HTFL is expected around Wed, Mar 17, 2027, after the close. For the quarter ended Sep 2026, HTFL reported EPS of -$0.13 on revenue of $72.9M, with revenue up 57.4% from a year ago. Over its last 6 reports the stock moved an average of 14.3% the session after earnings. Over the last 12 months HTFL insiders bought $1.1M of stock on the open market and sold $147.9M, according to SEC Form 4 filings.

AI Auto Pilots
Is HTFL in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold HTFL.

Key Stats

Last 12 months
Results
Revenue
$238.7M
+47.4% vs a year ago
Net income
−$79.0M
−33.1% margin
Free cash flow
−$56.1M
−23.5% margin
Gross margin
81.8%
$195.3M gross profit
Valuation
Market cap
$4.1B
87.9M shares
P/E
–
Price to sales
17.2
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$31.6M
At Sep 30
Shareholder equity
$282.5M
Shares outstanding
87.9M
At Oct 31
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2023: $87.2M$87.2MFY2023FY2024: $125.8M$125.8MFY2024FY2025: $176.0M$176.0MFY2025

From HTFL's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 12). Last 12 months adds up the four latest quarters.

Next report
Mar 17
Estimated date · After the close
Reported EPS
-$0.13
Quarter ended Sep 2026
Year ago EPS
-$1.04
Same quarter last year
Revenue
$72.9M
+57.4% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$5.74Dec '24Mar 2025: -$5.25Mar '25Jun 2025: -$1.46Jun '25Sep 2025: -$1.04Sep '25Dec 2025: $1.30Dec '25Mar 2026: -$0.32Mar '26Jun 2026: -$0.18Jun '26Sep 2026: -$0.13Sep '26Latest -$0.13
Revenue by quarter
Dec 2024: $35.0MDec '24Mar 2025: $37.2MMar '25Jun 2025: $43.4MJun '25Sep 2025: $46.3MSep '25Dec 2025: $49.1MDec '25Mar 2026: $52.6MMar '26Jun 2026: $64.1MJun '26Sep 2026: $72.9MSep '26Latest $72.9M
How HTFL moved after its last 6 reports
Average move the session after a report ±14.3%
Nov 12, 2026After the close−19.1%
Aug 13, 2026After the close+35.7%
May 14, 2026After the close−12.2%
Mar 18, 2026After the close+1.6%
Nov 12, 2025After the close−13.4%
Sep 10, 2025Time not announced−3.5%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on HTFLStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on HTFL
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on HTFL

Technical Analysis

HTFL · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend

The stock is 15% below its 20 day and 11% below its 50 day average. It is 24% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 41). The nearest support is the swing low (Oct 8) at $46.50, and the nearest resistance the Pivot R1 at $47.97.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 7.7%/day
Key levels
$60.6652 week high+29.9%
$53.7220 day average+15.1%
$51.7650 day average+10.9%
$50.82Swing high (Sep 14)+8.8%
$47.97Pivot R1+2.7%
$46.69Last close
$46.50Swing low (Oct 8)−0.4%
$45.88Pivot−1.7%
$44.59Pivot S1−4.5%
$43.43100 day average−7.0%
$35.66200 day average−23.6%
$20.1352 week low−56.9%
Indicators
RSI (14)40.89Middle of its rangeNeutral
MACD-1.59Below its signal lineBearish
Stochastic8.3Near the bottom of its rangeOversold
ADX (14)22.3Weak trend
Williams %R-82.8Oversold below −80, overbought above −20Oversold
CCI (20)-128.4Oversold below −100, overbought above 100Oversold
Rate of change−10.9%Change over 10 sessionsBearish
ATR (14)$3.61Typical daily range, 7.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for HTFL

What happened before

See how HTFL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Whale Options Flow

90D
Whale options flow for HTFLHow many large options trades hit HTFL, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

HTFL Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲164 buying vs 96 selling
  • ●Held by funds -0.5 pts
  • ▲Funds holding +56
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding250194+28.9%
In funds' top 1052+150.0%
Held by funds84.6%85.1%−0.5 pts
New / increased84 / 8050 / 91+16.3%
Reduced / sold out67 / 2937 / 24+57.4%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See HTFL institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

HTFL Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$1.1M1 buy · 1 insider
Sold$147.9M33 sales · 5 insiders
22% of the selling was under pre-arranged trading plans.
2025-12 bought $1.1M2026-02 sold $58.5M2026-03 sold $2.4M2026-04 sold $61.1M2026-05 sold $918K2026-06 sold $2.0M2026-07 sold $863K2026-08 sold $4.5M2026-09 sold $7.8M2026-10 sold $3.2M2026-11 sold $6.6MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 17Campbell RogersChief Medical OfficerSale plan111,412$37.86$4.2M
Nov 10John C.M. FarquharCEOSale plan38,900$55.74$2.2M
Nov 9Vikram VergheseCFOSale plan3,587$53.15$191K
Oct 22Campbell RogersChief Medical OfficerSale plan23,933$55.01$1.3M
Oct 12John C.M. FarquharCEOSale plan38,900$49.57$1.9M
Sep 18Campbell RogersChief Medical OfficerSale plan19,682$50.15$987K
Every insider buy and sale for HTFL over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See HTFL insider trades →

From SEC Form 4 filings by HTFL's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HTFL is in one of them and how their past HTFL trades turned out.

HTFL in the AI portfolios
Loading…

HTFL News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered HTFL in an article yet. Here's the latest on the wider market.

HTFL in the news

About Heartflow

Heartflow makes AI software that analyzes standard coronary CT angiography scans to help doctors diagnose and manage coronary artery disease, a leading cause of death. The software builds a personalized 3D model of a patient's heart from a single scan and reports on blood flow, narrowing and plaque. Its customers are hospitals and outpatient imaging centers, where cardiologists and radiologists use the tools in their routine workflows. The company is based in San Francisco, California.

Headquarters
San Francisco, CA